Modelling the impact of a new tobacco product: review of Philip Morris International's Population Health Impact Model as applied to the IQOS heated tobacco product. Read more about Modelling the impact of a new tobacco product: review of Philip Morris International's Population Health Impact Model as applied to the IQOS heated tobacco product.
Philip Morris International-funded 'Foundation for a Smoke-Free World': analysing its claims of independence. Read more about Philip Morris International-funded 'Foundation for a Smoke-Free World': analysing its claims of independence.
Heated tobacco products: another tobacco industry global strategy to slow progress in tobacco control. Read more about Heated tobacco products: another tobacco industry global strategy to slow progress in tobacco control.
Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke. Read more about Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke.
Keeping tobacco cheap: how tobacco companies undermine government tax measures. Read more about Keeping tobacco cheap: how tobacco companies undermine government tax measures.
Assessment of industry data on pulmonary and immunosuppressive effects of IQOS. Read more about Assessment of industry data on pulmonary and immunosuppressive effects of IQOS.
IQOS: examination of Philip Morris International's claim of reduced exposure. Read more about IQOS: examination of Philip Morris International's claim of reduced exposure.
Electronic cigarette chemicals transfer from a vape shop to a nearby business in a multiple-tenant retail building. Read more about Electronic cigarette chemicals transfer from a vape shop to a nearby business in a multiple-tenant retail building.
